NCT07082179 2026-02-11A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung CancerJiangsu Cancer Institute & HospitalPhase 2 Recruiting33 enrolled